|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| OPERATING ACTIVITIES: | ||||
| Income (loss) | ||||
| Adjustments in respect of income and expenses not involving cash flow: | ||||
| Share-based compensation to employees and service providers | ||||
| Depreciation | ||||
| Amortization of intangible assets | ||||
| Gains from early termination of leases, and impairment of fixed assets, net | ||||
| Gain on loss of control ( presented as part of a discontinued operations) | ||||
| Share from profit of joint venture | ||||
| Loss from global termination agreement (See note 15(6)(b)) and below | ||||
| Fair value (gains) losses on derivative financial instruments, recognition of day 1 loss and changes in royalty obligation | ||||
| Issuance costs in respect of warrants | ||||
| Issuance costs in respect of warrants and equity line of credit | ||||
| Exchange differences and revaluation of bank deposits | ||||
| Total adjustments in respect of income and expenses not involving cash flow | ||||
| Changes in assets and liability items: | ||||
| Decrease in trade receivables | ||||
| Decrease (increase) in prepaid expenses and other receivables | ||||
| Decrease (increase) in inventories (excluding THI transaction) | ||||
| Decrease in accounts payable | ||||
| Increase (decrease) in accrued expenses and other liabilities | ||||
| Decrease in allowance for deductions from revenue | ||||
| Total changes in assets and liability items | ||||
| Net cash used in operating activities | ||||
| Net cash used in operating activities from discontinued operation | ||||
| Net cash used in operating activities from continuing operation | ||||
| INVESTING ACTIVITIES: | ||||
| Purchase of fixed assets | ||||
| Proceeds from investment in joint venture | ||||
| Reconciliation related to receivable from joint venture | ||||
| Net cash provided by (used in) investing activities | ||||
| Net cash provided by investing activities from discontinued operation (see loss of control appendix below) | ||||
| Net cash (used in) provided by investing activities from continuing operation | ||||
| FINANCING ACTIVITIES: | ||||
| Decrease in restricted cash | ||||
| Payment of principal with respect to lease liabilities | ||||
| Net cash provided by financing activities | ||||
| Net cash provided by financing activities from discontinued operation | ||||
| Net cash provided by financing activities from continuing operation | ||||
| DECREASE IN CASH AND CASH EQUIVALENTS | ||||
| EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS | ||||
| BALANCE OF CASH AND CASH EQUIVALENTS AT THE BEGINNING OF YEAR | ||||
| BALANCE OF CASH AND CASH EQUIVALENTS AT THE END OF YEAR | ||||
| SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH | ||||
| SUPPLEMENTARY INFORMATION ON INTEREST PAID IN CASH | ||||
| SUPPLEMENTARY INFORMATION ON NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||||
| Acquisition of right-of-use assets by means of lease liabilities | ||||
| Decrease in lease liability (with corresponding decrease in right of use asset: none during 2025 and amount of $166 in 2024 ) | ||||
| Loss of control of Talicia Holdings Inc.: | ||||
| Derecognition of assets | ||||
| Derecognition of intangible assets | ||||
| Derecognition of inventory | ||||
| Recognition of investment in joint venture | ||||
| Gain on loss of control | ||||
| Proceeds from investment in joint venture | ||||
Loading...